Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sunitinib in Kaposi's Sarcoma in East Africa
NCT00521092Phase 2Withdrawn
- Sponsor
- National Cancer Institute
- Start
- Jan 2009
- Primary completion
- Oct 2010
01
Overview
A Phase 2 trial of sunitinib in Kaposi sarcoma (KS), sponsored by National Cancer Institute. Planned start Jan 2009; status: withdrawn.
02
Drugs
sunitinib
03
Conditions
Kaposi sarcoma (KS)
Beyond the preview
Go deeper on NCT00521092.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00521092.